Tafixyl™ I.V. (Tranexamic acid 100 mg/ml; 5 ml ● 10 ml)
Product Description
Pharma Bavaria International GmbH
-
DE
-
2018On CPHI since
-
1Certificates
-
25 - 49Employees
Company types
Primary activities
Categories
Specifications
Pharma Bavaria International GmbH
-
DE
-
2018On CPHI since
-
1Certificates
-
25 - 49Employees
Company types
Primary activities
More Products from Pharma Bavaria International GmbH (2)
-
Product Parafusiv™ I.V. | Vitopeine™ I.V. (Paracetamol 10 mg/ml; 100 ml ● 50 ml)
Vitopeine™ is indicated for the short-term treatment of moderate pain, especially following surgery & treatment of fever, when administration by intravenous routeis clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.
... -
Product Zolimetax™ I.V. (Zoledronic acid 4 mg/5 ml ● 4 mg/100 ml)
Prevention of skeletal-related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in patients with advanced malignancies involving bone. Treatment of tumour-induced ypercalcaemia.
Brand names/trademarks might be subject to local...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance